Skip to main content

Month: April 2022

Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2021

Revenue of $52.4 million for the year and $15.6 million for the 4th quarter; Adj. EBITDA of $9.8 million for the year and $3.0 million for the quarter BEVERLY, Mass. and TORONTO, April 07, 2022 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the fourth quarter and year-ended December 31, 2021. Financial HighlightsSales increased 32% to $52.4 million for the year-ended December 31, 2021; up 27% to $15.6 million for the fourth quarter. Sales in constant currency increased 28% for the year; 28% for the quarter. Gross profit increased 29% to $26.2 million for the year; up 22% to $7.9 million for the quarter. Net income...

Continue reading

Angus Gold Acquires Additional Property at the Golden Sky Project, Wawa

Figure 1 The Golden Sky Project Geology MapTORONTO, April 07, 2022 (GLOBE NEWSWIRE) — Angus Gold Inc. (TSX-V: GUS | OTC: ANGVF) (“Angus” or the “Company”) is pleased to announce that it has completed the acquisition of a 100% interest in key mineral claims (the “Acquisition Claims”) that are contiguous and adjacent to the Golden Sky Project located near Wawa, Ontario. The Golden Sky project, situated between Wesdome Gold Mines’ Eagle River and past-producing Mishi Pit mines, is the site of significant new gold discoveries in the banded iron formation horizon (“BIF”) and also hosts an historic gold resource in the Dorset Zone. The consolidated Golden Sky land package now stands at 267 square kilometres.   Steve Burleton, Chief Executive Officer of Angus, states: “We are extremely pleased with the success Angus has achieved in...

Continue reading

Constellation Brands Reports Fiscal Year and Fourth Quarter 2022 Financial Results and Fiscal Year 2023 Outlook

VICTOR, N.Y., April 07, 2022 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, reported today its fiscal year and fourth quarter 2022 financial results and fiscal year 2023 outlook. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer Bill Newlands and Chief Financial Officer Garth Hankinson on Thursday, April 7, 2022 at 10:30 a.m. (EDT). Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call. ABOUT CONSTELLATION BRANDS At Constellation Brands (NYSE: STZ and STZ.B), our mission is to build brands that people love because we believe sharing a toast, unwinding after a day, celebrating milestones, and helping people connect, are Worth Reaching...

Continue reading

Yoshitsu Co., Ltd Announces New Partnership to Optimize International Warehouse Operations

Tokyo, Japan, April 07, 2022 (GLOBE NEWSWIRE) — Yoshitsu Co., Ltd (“Yoshitsu” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, as well as other products in Japan, today announced that it has signed a further supplement to a service agreement, as previously supplemented (collectively, the “Agreement”) on February 25, 2022 with two cross-border E-commence, warehousing and logistics companies, Hainan Lion Cross Border E-Commerce Company Limited (“Hainan Lion”) and Lion (Hong Kong) Limited (“LHK”) (collectively, the “Lion Group”), further modifying and amending the original service agreement entered into on March 25, 2021, between the Company and Hainan Lion, to optimize international warehouse operations for expanding the Company’s business presence in China. Pursuant to the Agreement,...

Continue reading

Impel NeuroPharma To Present At The 21st Annual Needham Healthcare Conference

SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) — Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system, today announced that Adrian Adams, Chairman and Chief Executive Officer, will present a company overview at the 21st Annual Needham Healthcare Conference being held virtually on Thursday, April 14, 2022 at 1:30 p.m. ET. A live webcast of the event will be available on the Investors section of the Impel NeuroPharma website at https://investors.impelnp.com/. A replay of the presentation will be available on the website for 90 days. About Impel NeuroPharmaImpel NeuroPharma, Inc. is a commercial-stage biopharmaceutical company developing transformative therapies...

Continue reading

GreenBox Purchases Sky Financial Securing Estimated $1 Billion Processing Portfolio

Acquisition Brings Large Processing Volume Portfolio In-House, Enhancing Margins and Creating Additional Revenue Generating Opportunities SAN DIEGO, CA, April 07, 2022 (GLOBE NEWSWIRE) — GreenBox POS (NASDAQ: GBOX) (“GreenBox” or the “Company”), an emerging and rapidly growing Fintech company announced today it has entered into and closed on an asset purchase agreement with Sky Financial & Intelligence (“Sky”) to purchase a portfolio of merchant accounts for $16 million in cash and 500,000 restricted common shares. The shares distribution in connection with this transaction is not dilutive at this time, as they were previously loaned to the Company by its senior management in order to maintain compliance with the non-dilution provisions specified in the $100 million note issued to the Company on November...

Continue reading

Webinar: Piezo Motion’s Miniature Motors Are Driving Next Generation of Medical Devices

On April 21, Dr. Mark Broderick will discuss how Piezo Motion is revolutionizing the miniature-motor industry and providing viable solutions in high-tech industries LAKEWOOD RANCH, Fla., April 07, 2022 (GLOBE NEWSWIRE) — via InvestorWire — On April 21, Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, will host a webinar discussing its miniature precision motors and the new opportunities they create for medical devices and high-tech industries. Dr. Mark Broderick, Ph.D., will analyze the stability and accuracy of Piezo Motion’s multifaceted rotary and linear miniature motors, designed specifically for medical device manufacturers requiring improved speed, size and accuracy. “Our motion solutions are enabling a new generation of high tech and medical devices,” said Hassan Kotob, chairman and CEO of Brain Scientific. “Traditionally,...

Continue reading

Enphase Energy Expands Battery Storage in Nevada

FREMONT, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, announced today that installers of Enphase® products in Nevada have seen growing deployments of the Enphase Energy System, powered by IQ™ Microinverters and IQ™ Batteries. Residential battery capacity is growing in Nevada, with forecasts estimating deployments will multiply nearly six-fold by 2026, according to the most recent U.S. Energy Storage Monitor report from the Energy Storage Association and Wood Mackenzie. In addition, Nevada homeowners can now choose to install Enphase’s revolutionary IQ8™ Microinverters. IQ8-based systems can provide Sunlight Backup during an outage, even without a battery. For homeowners who...

Continue reading

Bionano Genomics Announces Release of Version 6.2 of its NxClinical Software with Significant New Capabilities for Cancer Research Applications Including HRD Analysis

Version includes a powerful capability for genomic scar analysis for assessments of homologous recombination deficiency (HRD) that provides an efficient, consistent approach for analysis of tumor biomarkers used in pharmacogenomics and other cancer research SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the leading solution for visualization, interpretation and reporting of genomic data, today announced the launch of an integrated genomic scar analysis for homologous recombination deficiency (HRD) in the version 6.2 software release of NxClinical. This feature provides a comprehensive, consistent, and automated analysis of biomarkers from next-generation sequencing (NGS) and microarray data...

Continue reading

Rogue Station Companies Inc./Everdime Inc. Adds Seasoned High-Level Banking CEO to its Board of Directors

Grant MacKenzie currently serves as president of Peoples Bank of Canada Sheridan, Wyoming, April 07, 2022 (GLOBE NEWSWIRE) — Rogue Station Companies, Inc./Everdime Inc. (OTC Pink: RGST) is extremely pleased to announce the addition of Grant MacKenzie to its Board of Directors. Mr. MacKenzie is the President and CEO of Peoples Group, Peoples Trust Company and Peoples Bank of Canada. He has more than 40 years of executive and financial management experience in the Banking/Financial Services industries. Peoples Group was founded in 1985 and is based in Vancouver, Canada. They have over 300 employees in Canada and manage more than $19 billion in assets. Mr. MacKenzie commented, “Sandor’s plan to position Everdime in NFT development and trading within the Crypto space is smart and on track. NFTs and Meta Verse are the new...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.